Sec. 1369.213.  PROHIBITED CONDUCT.  (a)  A health benefit plan that provides coverage for stage-four advanced, metastatic cancer and associated conditions may not require, before the health benefit plan provides coverage of a prescription drug approved by the United States Food and Drug Administration, that the enrollee:
(1)  fail to successfully respond to a different drug; or
(2)  prove a history of failure of a different drug.
(b)  This section applies only to a drug the use of which is:
(1)  consistent with best practices for the treatment of stage-four advanced, metastatic cancer or an associated condition;
(2)  supported by peer-reviewed, evidence-based literature; and
(3)  approved by the United States Food and Drug Administration.
Added by Acts 2019, 86th Leg., R.S., Ch. 1350 (H.B. 1584), Sec. 1, eff. September 1, 2019.